PCN125 AN ECONOMICAL, RANDOMIZED, MULTICENTER PHASE III TRIAL OF SECOND LINE TREATMENT FOR NON SMALL CELL LUNG CANCER (NSCLC) COMPARING DOCETAXEL VERSUS PEMETREXED- GFPC (GROUPE FRANROLOGIE) 05-06 STUDY
Abstract
Authors
A Vergnenegre R Corre H Berard D Paillotin C Dujon G Robinet J Crequit S Bota P Thomas C Chouaid